首页> 外文期刊>Virology >A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo
【24h】

A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo

机译:不能有效利用CCR5或常见替代共受体的猿猴免疫缺陷病毒V3环突变体在体内被减毒

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sexually transmitted HIV-1 strains utilize the chemokine receptor CCR5 for viral entry and inhibitors targeting this coreceptor offer great promise for antiretroviral therapy. They also raise the question, however, whether viral variants exhibiting altered coreceptor interactions and resistance against these antiviral agents might still be pathogenic. In the present study, we analyzed a SIVmac239 envelope (Env) mutant (239DL) containing two mutations in the V3 loop which reduced viral entry via CCR5 by 10- to 20-fold, disrupted utilization of common alternative SIV coreceptors and changed the way Env engaged CCR5. To evaluate its replicative capacity and pathogenic potential in vivo we infected six rhesus macaques with 239DL. We found that 239DL replication was only slightly attenuated early during infection. Thereafter, a D324V change, which restored efficient CCR5 usage and coincided with 239wt-like levels of viral replication, emerged in two animals. In contrast, the viral geno- and phenotype remained stable in the other four rhesus macaques. Although these animals had about 100-fold reduced viral RNA loads relative to 239wt-infected macaques, they showed pronounced CD4 T-cell depletion in the intestinal lamina propria, and one developed opportunistic infections and died with simian AIDS. Thus, changes in the V3 loop that diminished CCR5 usage and altered Env interactions with CCR5 reduced the pathogenic potential of SIVmac in rhesus macaques but did not abolish it entirely. (c) 2006 Elsevier Inc. All rights reserved.
机译:性传播的HIV-1株利用趋化因子受体CCR5进入病毒,靶向该共受体的抑制剂为抗逆转录病毒疗法提供了广阔前景。他们也提出了一个问题,但是,表现出改变的共受体相互作用和对这些抗病毒剂的抗性的病毒变体是否仍可能是致病的。在本研究中,我们分析了SIVmac239包膜(Env)突变体(239DL),该突变体在V3环中包含两个突变,从而使通过CCR5的病毒进入减少了10至20倍,破坏了常见的替代SIV共受体的利用并改变了Env的方式参与CCR5。为了评估其在体内的复制能力和致病性,我们用239DL感染了六只恒河猴。我们发现239DL复制在感染过程的早期仅轻微减弱。此后,在两只动物中出现了D324V变化,该变化恢复了有效的CCR5使用,并与239wt%的病毒复制水平相吻合。相反,在其他四只猕猴中,病毒的基因型和表型保持稳定。尽管这些动物的病毒RNA载量相对于239wt感染的猕猴而言降低了约100倍,但它们在肠道固有层中显示出明显的CD4 T细胞耗竭,并且其中一只发生了机会性感染并死于猿猴AIDS。因此,V3回路中的变化减少了CCR5的使用并改变了Env与CCR5的相互作用,从而降低了猕猴中SIVmac的致病性,但并未完全消除。 (c)2006 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号